Портопульмональная гипертензия и гепатопульмональный синдром у больных циррозом печени

1. Гарбузенко Д.В. Патогенез портальной гипертензии при циррозе печени. Рос. журн. гастроэнтерол., гепатол., колопрокторол. 2002; 12 (5): 23–29.

2. Swanson K.L., Krowka M.J. Arterial oxygenation associated with portopulmonary hypertension. Chest 2002; 121 (6): 1869–1875.

3. Krowka M.J., Plevak D.J., Findlay J.Y. et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transplant. 2000; 6 (4): 443–450.

4. Auletta M., Oliviero U., Iasinolo L. et al. Pulmonary hypertension associated with liver cirrhosis: an echocardiographic study. Angiology 2000; 51 (12): 1013–1020.

5. Benjaminov F.S., Prentice M., Sniderman K.W. et al. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 2003; 52 (9): 1355–1362.

6. Robalino B.D., Moodie D.S. Association between primary pulmonary hypertension and portal hypertension: analysis of pathophysiology, clinical, laboratory, and hemodynamic manifestations. J. Amer. Coll. Cardiol. 1991; 17: 492–498.

7. Патарая С.А., Преображенский Д.В., Сидоренко Б.А., Масенко В.П. Биохимия и физиология семейства эндотелинов. Кардиология 2000; 40 (6): 78–85.

8. Krowka M.J., Edwards W.D. A spectrum of pulmonary vascular pathology in portopulmonary hypertension. Liver Transplant. 2000; 6 (2): 241–242.

9. Pilatis N.D., Jacobs L.E., Rerkpattanapipat P. et al. Clinical predictors of pulmonary hypertension in patients undergoing liver transplant evaluation. Liver Transplant. 2000; 6 (1): 85–91.

10. Naeije R. Hepatopulmonary syndrome and portopulmonary hypertension. Swiss. Med. Wkly 2003; 133 (11–12): 163–169.

11. Cotton C.L., Gandhi S., Vaitkus P.T., et al. Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. Liver Transplant. 2002; 8 (11): 1051–1054.

12. Kim W.R., Krowka M.J., Plevak D.J. et al. Accuracy of doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transplant. 2000; 6 (4): 453–458.

13. Щетинин В.В., Берестень Н.Ф. Кардиосовместимая допплерография. М.: Медицина; 2002.

14. Colle I.O., Moreau R., Godinho E. et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 2003; 37 (2): 401–409.

15. Hoeper M.M., Krowka M.J., Strassburg C.P. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004; 363: 1461–1468.

16. Беленков Ю.Н. Лечение первичной легочной гипертонии: сто лет поисков и разочарований. Тер. арх. 1998; 70 (9): 16–18.

17. Kahler C.M., Graziadei I., Wiedermann C.J. et al. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension. Wien. Klin. Wschr. 2000; 112 (14): 637–640.

18. Swanson K.L., McGoon M.D., Krowka M.J. Survival in patients with portopulmonary hypertension. Am. J. Respir. Crit. Care Med. 2003; 167: A693.

19. Findlay J.Y., Plevak D.J., Krowka M.J. et al. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. Liver Transplant. Surg. 1999; 5: 362–365.

20. Kato H., Katori T., Nakamura Y., Kawarasaki H. Moderateterm effect of epoprostenol on severe portopulmonary hypertension. Pediatr. Cardiol. 2003; 24 (1): 50–53.

21. Schroeder R.A., Rafii A.A., Plotkin J.S., et al. Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension. Transplantation 2000; 70 (3): 548–550.

22. Минушкина Л.О., Затейщиков Д.А., Сидоренко Б.А. Блокаторы эндотелиновых рецепторов — еще одно средство для лечения легочной гипертонии. Кардиология 2003; 43 (9): 67–71.

23. Ghofrani H.A., Rose F., Schermuly R.T. et al. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J. Am. Coll. Cardiol. 2003; 42: 158–164.

24. Krowka M.J., Susan Mandell M., Ramsay M.A.E. et al. Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database. Liver Transplant. 2004; 10 (2): 174–182.

25. Anand A.C., Mukherjee D.D., Rao K.S., Seth A.K. Hepatopulmonary syndrome: prevalence and clinical profile. Indian J. Gastroenterol. 2001; 20 (1): 24–27.

26. Krowka M.J. Hepatopulmonary syndromes. Gut 2000; 46: 1–4.

27. Krowka M.J., Wiseman G.A., Burnett O.L. et al. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100 % oxygen, and brain uptake after (99m)TcMAA lung scanning. Chest 2000; 118: 615–624.

28. Fiel M.I., Schiano T.D., Suriawinata A., Emre S. Portal hypertension and hepatopulmonary syndrome in a middleaged man with hepatitis B infection. Semin. Liver. Dis. 2000; 20 (3): 391–395.

29. Kaymakoglu S., Kahraman T., Kudat H. et al. Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Dig. Dis. Sci. 2003; 48 (3): 556–560.

30. De B.K., Sen S., Biswas P.K., Mandal S.K. et al. Occurrence of hepatopulmonary syndrome in Budd–Chiari syndrome and the role of venous decompression. Gastroenterology 2002; 122 (4): 897–903.

31. Teuber G., Teupe C., Dietrich C.F. et al. Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis. Eur. J. Intern. Med. 2002; 13 (5): 311–318.

32. Krowka M.J., Dickson E.R., Cortese D.A. Hepatopulmonary syndrome: clinical observations and lack of therapeutic response to somatostatin analogue. Chest 1993; 104: 515–521.

33. Schroeder R.A., Ewing C.A., Sitzmann J.V., Kuo P.C. Pulmonary expression of iNOS and HO-1 protein is upregulated in a rat model of prehepatic portal hypertension. Dig. Dis. Sci. 2000; 45 (12): 2405–2410.

34. Rolla G., Brussino L., Colagrande P. et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 1997; 26 (4): 842–847.

35. Luo B., Liu L., Tang L. et al. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 286 (2): 294–303.

36. Schraufnagel D.E., Kay J.M. Sructural and pathologic changes in the lung vasculature in chronic liver disease. Clin. Chest Med. 1996; 17: 1–15.

37. Hira H.S., Kumar J., Tyagi S.K., Jain S.K. A study of hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension. Indian J. Chest Dis. Allied Sci. 2003; 45 (3): 165–171.

38. Gautier1Brun V., Beurton1Chataigner I., Manzoni P. et al. The hepatopulmonary syndrome. Presse Med. 2002; 31 (6): 271–280.

39. Paramesh A.S., Husain S.Z., Shneider B. et al. Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature. Pediatr. Transplant. 2003; 7 (2): 157–162.

40. Rabiller A., Nunes H., Lebrec D. et al. Prevention of gramnegative translocation reduces the severity of hepatopulmonary syndrome. Am. J. Respir. Crit. Care Med. 2002; 166: 514–517.

41. Van Obbergh L.J., Carlier M., De Kock M. et al. Hepatopulmonary syndrome and liver transplantation: a review of the preoperative management of seven paediatric cases. Paediatr. Anaesth. 1998; 8 (1): 59–64.